mi_priorexam revpro_date
Name
ptca_date
Label
Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
Description

Time since Sleep Heart Health Study Visit One (SHHS 1) Sleep Study to date of first Percutaneous transluminal coronary angioplasty (PTCA)

Units
days from index date
Type
numeric
Tags
adjudicated tto_ptcadate
Sleep Heart Health Study (SHHS) Visit Number vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
N Mean StdDev Median Min Max Unknown Total
Visit 1 - - - - - - - -
Interim Follow-up Visit - - - - - - - -
Visit 2 - - - - - - - -
CVD Outcomes 311 2,038.3 ± 1,256.7 1,915.0 21.0 5,231.0 5,491 5,802
Gender of the participant vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
CVD Outcomes
N Mean StdDev Median Min Max Unknown Total
Total 311 2,038.3 ± 1,256.7 1,915.0 21.0 5,231.0 5,491 5,802
Male 214 1,984.5 ± 1,232.9 1,891.5 21.0 5,006.0 2,551 2,765
Female 97 2,157.0 ± 1,306.3 1,952.0 33.0 5,231.0 2,940 3,037
Race of the participant vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
CVD Outcomes
N Mean StdDev Median Min Max Unknown Total
Total 311 2,038.3 ± 1,256.7 1,915.0 21.0 5,231.0 5,491 5,802
White 282 2,062.3 ± 1,253.9 1,959.0 21.0 5,231.0 4,625 4,907
Black 13 1,149.7 ± 729.1 910.0 251.0 2,394.0 502 515
Other 16 2,337.8 ± 1,403.1 2,017.0 441.0 4,748.0 364 380